| |
The aim of this long-term study is to understand more thoroughly the risk factors and course of Obsessive-Compulsive Disorder. Over several years, researchers will follow families in which there is at least one child or parent with childhood onset OCD and at least one OCD-unaffected child in an effort to discover specific genetic, brain, neuropsychological, psychosocial, and diagnostic factors that put people at risk for developing the disorder. By the end of the study, researchers hope to have better insight into the causes of OCD—insight that will help in the development of better prevention and treatment approaches. Please visit the study’s website for more details: www.ocdfamilystudy.org Or call 1-877-CURE-OCD (877-287-3623)
|
|
| |
| |
|
|
|
|
|
|
This study is examining which areas of the brain are involved in attention (the ability to think, reason, and remember) in OCD. We are trying to understand whether people with OCD use certain areas of the brain differently than control participants or individuals with other disorders (schizophrenia, autism spectrum disorders) when performing tests of attention that involve eye movements. Different scans will be used to take pictures of your brain (Magnetic Resonance Imaging [MRI]) and brain function (special high-speed functional MRI [fMRI; MEG and EEG]) during certain tasks. This study will also look at your genes to find out if there are relationships between genes and brain function.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
This study seeks to examine potential underlying cultural and ethnic factors in the manifestation of Obsessive-compulsive Disorder using a simple, easy to use survey. This study aims to identify disparities in healthcare between different ethnic, religious and socioeconomic backgrounds as well as different sexual orientations and genders. Please use this link to participate: www.surveymonkey.com/OCDSurvey
|
|
| |
| |
|
|
|
|
|
|
| |
This study is for people with OCD who are not currently taking any other psychiatric medications (other meds, including birth control, are fine). The study runs for 17 weeks, and involves 6 visits to our clinic in Charlestown. During the first visit subjects are interviewed about their past psychiatric history, and complete a variety of questionnaires. The first study visit is the longest (1-2 hours), but visits after that take 20-30 minutes each. At these visits, subjects fill out some short symptom assessments, and discuss how treatment is going for them. At the final visit we will assess the patients' progress and discuss future treatment options. There is no compensation for the study, but the medication is provided free of charge. Patients who wish to enroll must not be on any psychiatric medications, nor can they be undergoing current behavior therapy. Patients with comorbid bipolar disorder or psychosis are excluded, as are patients who have had a depressive episode in the last 12 months.
|
|
| |
| |
|
|
|
|
|
|
|
|
|
|
